Blood test may guide safer heart failure discharge
NCT ID NCT03103932
First seen May 11, 2026 · Last updated May 11, 2026
Summary
This study looks at whether measuring a heart failure biomarker (NTproBNP) in the blood can help doctors decide the best time to discharge patients from the hospital. About 750 adults admitted for worsening heart failure will be randomly assigned to either usual care or a discharge plan guided by their biomarker levels. The goal is to see if the biomarker-guided approach helps patients spend more days alive and out of the hospital during the first month after discharge.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE; WITH DECOMPENSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, K1Y 4W7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.